PMCB
PHARMACYTE BIOT (PMCB)
NASDAQ
$0.58+$0.008 (+1.39%)
Price as of Aug 03, 2026 11:35 AM EDT
  • $6.2M
    Market Cap
  • -42.40%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
04/30/2026
04/30/2025
04/30/2024
04/30/2023
Income Statement
Total Operating Revenue
0
N/A
0
N/A
0
N/A
0
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-391,301
-10.75%
-438,416
+7.60%
-407,431
-13.04%
-468,536
-32.19%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
6.9M
+56.55%
4.4M
-48.62%
8.5M
+31.98%
6.5M
+46.98%
Operating Profit
-6.9M
+56.55%
-4.4M
-48.62%
-8.5M
+31.98%
-6.5M
+46.98%
Interest Income
733,351
-48.19%
1.4M
-58.35%
3.4M
+75.42%
1.9M
+1,129.03%
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
0
+100.00%
Interest Income and Expense and Net
733,351
-48.19%
1.4M
-58.35%
3.4M
+75.42%
1.9M
+1,133.01%
Total Nonoperating Income and Expense
-12.6M
-135.88%
35.0M
+295.69%
8.9M
+313.82%
2.1M
+1,299.71%
Income before Taxes
-23.2M
-199.33%
23.4M
+235.53%
-17.2M
+167.02%
-6.5M
+46.98%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
1.6M
0.00%
1.6M
N/A
N/A
N/A
Net Income
-23.2M
-199.33%
23.4M
+6,899.61%
333,763
+107.73%
-4.3M
+1.81%
Net Income from Continuing Operations Applicable to Common
-23.2M
-199.33%
23.4M
+235.53%
-17.2M
+299.38%
-4.3M
+1.81%
Basic EPS and Net Income
-2.77
-186.83%
3.19
+277.22%
-1.80
+718.18%
-0.22
-18.52%
Diluted EPS and Net Income
-2.77
-186.83%
3.19
+277.22%
-1.80
+718.18%
-0.22
-18.52%
Basic Weighted Average Shares
8.4M
+14.31%
7.3M
-23.50%
9.6M
-50.84%
19.5M
+25.56%
Diluted Weighted Average Shares
8.4M
+14.31%
7.3M
-23.50%
9.6M
-50.84%
19.5M
+25.56%
Balance Sheet
Cash and Cash Equivalents
18.6M
+22.62%
15.2M
-69.76%
50.2M
-26.25%
68.0M
-20.33%
Short-Term Investments
254,010
-30.66%
366,316
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
18.9M
+21.36%
15.5M
-69.03%
50.2M
-26.25%
68.0M
-20.33%
Total Current Assets
37.4M
+67.24%
22.4M
-55.64%
50.4M
-25.98%
68.1M
-20.29%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
9.3M
-71.54%
32.8M
+246.50%
9.5M
+84.51%
5.1M
0.00%
Total Assets
46.8M
-15.25%
55.2M
-7.91%
59.9M
-18.25%
73.3M
-19.14%
Income Taxes Payable
338,021
+0.65%
335,846
+19.10%
281,976
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
826,424
-71.64%
2.9M
-60.73%
7.4M
+1,165.17%
586,581
-16.72%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
10.9M
+3,138.46%
338,000
-97.39%
13.0M
N/A
N/A
N/A
Total Liabilities
11.8M
+259.21%
3.3M
-83.93%
20.4M
+3,375.95%
586,581
-16.72%
Retained Earnings
-104.4M
+22.86%
-85.0M
-26.51%
-115.6M
-0.29%
-116.0M
+3.86%
Total Stockholders Equity
33.3M
-35.84%
51.9M
+87.69%
27.6M
-61.97%
72.7M
-19.16%
Total Shares Outstanding
10.7M
+57.98%
6.8M
-15.45%
8.0M
-52.14%
16.8M
+956.17%
Cash Flow
Cash from Operating Activities
-5.2M
+73.02%
-3.0M
+38.43%
-2.2M
-43.29%
-3.8M
-7.86%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
2.0M
+128.57%
-7.0M
+40.00%
-5.0M
N/A
0
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
6.6M
+126.30%
-25.0M
+133.74%
-10.7M
-21.03%
-13.6M
-115.53%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-45.54%
-212.15%
40.60%
+8,001.40%
0.50%
+109.52%
-5.27%
-39.11%
Return on Equity
-54.48%
-192.75%
58.74%
+8,729.70%
0.67%
+112.53%
-5.31%
-39.52%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
45.28
+489.75%
7.68
+12.96%
6.80
-94.15%
116.18
-4.28%
Cash Ratio
22.51
+332.40%
5.21
-23.00%
6.76
-94.17%
115.99
-4.33%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow